Stay updated on HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial

Sign up to get notified when there's something new on the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record, with the 403 header and a site footer visible, indicating the trial details are inaccessible at this time.
    Difference
    19%
    Check dated 2026-09-19T19:13:35.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6. This reflects a version bump for the page rather than a substantive change to study details.
    Difference
    0.1%
    Check dated 2026-08-29T19:56:26.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, representing a small backend/content management update.
    Difference
    0.1%
    Check dated 2026-08-08T18:29:47.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page’s revision metadata updated from v3.6.3 to v3.6.4, indicating a new version of the page.
    Difference
    0.1%
    Check dated 2026-07-25T11:40:21.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3, reflecting a minor update to the study record documentation.
    Difference
    0.1%
    Check dated 2026-07-03T23:54:20.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    The revision tag in the page footer was updated from v3.6.0 to v3.6.2, indicating a newer platform release.
    Difference
    0.1%
    Check dated 2026-06-26T22:31:40.000Z thumbnail image

Stay in the know with updates to HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page.